Johnson & Johnson (JNJ) Cash from Operations (QoQ) (2009 - 2026)

Johnson & Johnson (JNJ) Cash from Operations (QoQ) (2009 - 2026) Analysis & Trends

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn
10 Novartis Ag 109.78 Bn 109.09 Bn -

Historic Data

Download Data
DateValue
Mar 29, 2026 -65.60%
Dec 28, 2025 -20.29%
Sep 28, 2025 136.44%
Jun 29, 2025 -7.09%
Mar 30, 2025 -40.23%
Dec 29, 2024 -12.64%
Sep 29, 2024 41.90%
Jun 30, 2024 54.03%
Mar 31, 2024 -53.49%
Dec 31, 2023 4.99%
Oct 1, 2023 79.08%
Jul 2, 2023 28.40%
Apr 2, 2023 -7.37%
Oct 3, 2021 56.00%
Jul 4, 2021 30.44%
Apr 4, 2021 -51.17%
Jan 3, 2021 -0.48%
Sep 27, 2020 142.84%
Jun 28, 2020 2.80%
Mar 29, 2020 -47.51%